MiMedx Group, Inc.
MDXG
$3.56
$0.010.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 389.42M | 418.63M | 393.44M | 363.77M | 352.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 389.42M | 418.63M | 393.44M | 363.77M | 352.38M |
| Cost of Revenue | 73.82M | 73.01M | 70.87M | 67.47M | 63.64M |
| Gross Profit | 315.59M | 345.62M | 322.58M | 296.30M | 288.73M |
| SG&A Expenses | 259.46M | 266.19M | 254.21M | 239.37M | 220.92M |
| Depreciation & Amortization | 642.00K | 440.00K | 504.00K | 584.00K | 674.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 349.83M | 354.74M | 339.48M | 320.55M | 298.07M |
| Operating Income | 39.59M | 63.89M | 53.96M | 43.23M | 54.31M |
| Income Before Tax | 42.32M | 66.26M | 55.72M | 44.29M | 54.50M |
| Income Tax Expenses | 11.62M | 17.68M | 14.89M | 12.33M | 14.54M |
| Earnings from Continuing Operations | 30.70 | 48.58 | 40.83 | 31.96 | 39.96 |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 217.00K | 221.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.70M | 48.58M | 40.83M | 32.17M | 40.18M |
| EBIT | 39.59M | 63.89M | 53.96M | 43.23M | 54.31M |
| EBITDA | 52.86M | 78.75M | 68.59M | 53.72M | 62.78M |
| EPS Basic | 0.21 | 0.33 | 0.28 | 0.22 | 0.27 |
| Normalized Basic EPS | 0.18 | 0.28 | 0.24 | 0.19 | 0.23 |
| EPS Diluted | 0.20 | 0.32 | 0.27 | 0.21 | 0.27 |
| Normalized Diluted EPS | 0.18 | 0.28 | 0.23 | 0.19 | 0.23 |
| Average Basic Shares Outstanding | 592.33M | 591.16M | 590.08M | 589.00M | 588.57M |
| Average Diluted Shares Outstanding | 597.67M | 598.90M | 597.95M | 596.61M | 596.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |